Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2013, Article ID 761046, 11 pages
http://dx.doi.org/10.1155/2013/761046
Research Article

Genome-Wide Association Study of Antiphospholipid Antibodies

1Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
2Division of Rheumatology, Department of Medicine, West Penn Allegheny Health System, Pittsburgh, PA 15212, USA
3Divisions of Clinical Immunology/Allergy, and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, QC, Canada H3A 1A1
4Division of Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Received 5 November 2012; Revised 10 January 2013; Accepted 10 January 2013

Academic Editor: Ricard Cervera

Copyright © 2013 M. Ilyas Kamboh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Gharavi, W. A. Wilson, and D. J. Wallace, “Antphospholipid antibodies,” in Dubois'Lupus Erythematosus, B. H. Hahn, Ed., vol. 5th, pp. 471–491, Williams & Wilkins, Baltimore, Md, USA, 1997. View at Google Scholar
  2. R. A. S. Roubey, “Update on antiphospholipid antibodies,” Current Opinion in Rheumatology, vol. 12, no. 5, pp. 374–378, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Pierangeli, P. G. De Groot, J. Dlott et al., ““Criteria” aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010,” Lupus, vol. 20, no. 2, pp. 182–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Mackworth-Young, J. Chan, and N. Harris, “High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 14, no. 4, pp. 723–726, 1987. View at Google Scholar · View at Scopus
  5. F. Matthey, K. Walshe, I. J. Mackie, and S. J. Machin, “Familial occurrence of the antiphospholipid syndrome,” Journal of Clinical Pathology, vol. 42, no. 5, pp. 495–497, 1989. View at Google Scholar · View at Scopus
  6. T. Horita and J. T. Merrill, “Genetics of antiphospholipid syndrome,” Current rheumatology reports, vol. 6, no. 6, pp. 458–462, 2004. View at Google Scholar · View at Scopus
  7. E. Png, B. Alisjahbana, E. Sahiratmadja et al., “A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians,” BMC Medical Genetics, vol. 13, p. 5, 2012. View at Google Scholar
  8. S. Miehe, A. Bieberstein, I. Arnould, O. Ihdene, H. Rütten, and C. Strübing, “The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5,” Journal of Biological Chemistry, vol. 285, no. 16, pp. 12426–12434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Shitao, W. Lingyan, B. Michael et al., “Mapping of dynamic innate immunity protein interaction network regulating type I interferon production,” Immunity, vol. 35, pp. 426–440, 2011. View at Google Scholar
  10. Q. L. Song, X. X. He, H. Yang et al., “Association of TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population,” Viral Immunology, vol. 25, pp. 73–78, 2012. View at Google Scholar
  11. T. L. Mosbruger, P. Duggal, J. J. Goedert et al., “Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus,” Journal of Infectious Diseases, vol. 201, no. 9, pp. 1371–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. G. Pezzolesi, G. D. Poznik, J. C. Mychaleckyj et al., “Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus,” Nature Genetics, vol. 40, pp. 1092–1097, 2008. View at Publisher · View at Google Scholar
  13. S. Maeda, S. I. Araki, T. Babazono et al., “Replication study for the association between four loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes,” Diabetes, vol. 59, no. 8, pp. 2075–2079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Pezzolesi, G. D. Poznik, J. Skupien et al., “An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes,” Kidney International, vol. 80, no. 1, pp. 105–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gigante, M. L. Gasperini, R. Cianci et al., “Antiphospholipid antibodies and renal involvement,” American Journal of Nephrology, vol. 30, no. 5, pp. 405–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. G. Tektonidou, “Renal involvement in the antiphospholipid syndrome (APS) - APS nephropathy,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 2-3, pp. 131–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Silvarino, F. Sant, G. Espinosa et al., “Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus,” Lupus, vol. 20, pp. 721–729, 2011. View at Publisher · View at Google Scholar
  18. T. Mehrani and M. Petri, “IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus,” Journal of Rheumatology, vol. 38, no. 3, pp. 450–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Wang, C. Yu, Y. Lu et al., “TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis,” Apoptosis, vol. 12, pp. 1489–1502, 2007. View at Publisher · View at Google Scholar
  20. M. Pierdominici, M. Vomero, C. Barbati et al., “Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus,” FASEB Journal, vol. 26, pp. 1400–1412, 2012. View at Publisher · View at Google Scholar
  21. L. E. Mũoz, K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann, “The role of defective clearance of apoptotic cells in systemic autoimmunity,” Nature Reviews Rheumatology, vol. 6, no. 5, pp. 280–289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. -J. Chamorro, M. Marcos, J.-A. Miron-Canelo et al., “Val247Leu beta2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systemic review and meta-analysis,” Autoimmunity Reviews, vol. 11, pp. 705–712, 2012. View at Google Scholar
  23. D. K. Sanghera, D. R. Wagenknecht, J. A. McIntyre, and M. I. Kamboh, “Identification of structural mutations in the fifth domain of apolipoprotein H (β2-glycoprotein I) which affect phospholipid binding,” Human Molecular Genetics, vol. 6, no. 2, pp. 311–316, 1997. View at Publisher · View at Google Scholar · View at Scopus